We are live on
!
Find out more
FG
Fairman Group Portfolio holdings
AUM
$127M
Turnover
8.16%
1-Year Est. Return
6.28%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.6M
(+2.1%)
Cap. Flow
+$1.24M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
69.52%
Holding
284
New
27
Increased
59
Reduced
25
Closed
10
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.18M |
| 2 |
Diamond Hill Large Cap Concentrated ETF
DHLX
|
+$1.2M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$258K |
| 4 |
iMGP DBi Managed Futures Strategy ETF
DBMF
|
+$217K |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$102K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Essent Group
ESNT
|
+$1.46M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$374K |
| 3 |
Eaton Vance Enhance Equity Income Fund II
EOS
|
+$191K |
| 4 |
Calamos Strategic Total Return Fund
CSQ
|
+$107K |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$75.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.27% |
| 2 | Technology | 20.52% |
| 3 | Financials | 10.78% |
| 4 | Healthcare | 5.34% |
| 5 | Consumer Discretionary | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
OS
251
DELISTED
OneStream Inc
OS
| $627 | ﹤0.01% |
34
| – | – |
2024 Q4
3 quarters
|
|
252
Prudential
PUK
$29.6B
| $619 | ﹤0.01% |
22
| – | – |
2023 Q4
7 quarters
|
|
253
Tenet Healthcare
THC
$22.2B
| $609 | ﹤0.01% |
3
| – | – |
2023 Q4
7 quarters
|
|
254
Ambev
ABEV
$50.3B
| $527 | ﹤0.01% |
234
| – | – |
2023 Q4
7 quarters
|
|
255
DELISTED
Kellanova
K
| $492 | ﹤0.01% |
6
| – | – |
2023 Q4
7 quarters
|
|
256
SLB Ltd
SLB
$71.8B
| $485 | ﹤0.01% |
14
| – | – |
2023 Q4
7 quarters
|
|
257
DELISTED
Warner Bros
WBD
| $469 | ﹤0.01% |
24
| – | – |
2023 Q4
7 quarters
|
|
258
CVS Health
CVS
$118B
| $377 | ﹤0.01% |
5
| – | – |
2023 Q4
7 quarters
|
|
259
PENN Entertainment
PENN
$2.04B
| $289 | ﹤0.01% |
15
| – | – |
2023 Q4
7 quarters
|
|
260
Jackson Financial
JXN
$8.91B
| $202 | ﹤0.01% |
2
| – | – |
2023 Q4
7 quarters
|
|
261
Research Frontiers
REFR
$22.3M
| $199 | ﹤0.01% |
125
| – | – |
2023 Q4
7 quarters
|
|
262
Fulton Financial
FULT
$4.27B
| $168 | ﹤0.01% |
9
| – | – |
2024 Q1
6 quarters
|
|
263
Mattel
MAT
$4.95B
| $168 | ﹤0.01% |
10
| – | – |
2023 Q4
7 quarters
|
|
264
DELISTED
NeueHealth
NEUE
| $167 | ﹤0.01% |
25
| – | – |
2023 Q4
7 quarters
|
|
265
Organon & Co
OGN
$3.61B
| $162 | ﹤0.01% |
15
| – | – |
2023 Q4
7 quarters
|
|
266
GE HealthCare
GEHC
$31.8B
| $150 | ﹤0.01% |
2
| – | – |
2023 Q4
7 quarters
|
|
267
Immersion
IMMR
$237M
| $139 | ﹤0.01% |
19
| – | – |
2023 Q4
7 quarters
|
|
268
VistaGen Therapeutics
VTGN
$9.45M
| $103 | ﹤0.01% |
29
| – | – |
2023 Q4
7 quarters
|
|
269
DXC Technology
DXC
$2.2B
| $95 | ﹤0.01% |
7
| – | – |
2023 Q4
7 quarters
|
|
270
Resideo Technologies
REZI
$2.52B
| $86 | ﹤0.01% |
2
| – | – |
2023 Q4
7 quarters
|
|
271
Opendoor
OPEN
$2.25B
| $80 | ﹤0.01% |
+10
| New | +$41 |
2025 Q3
0 quarters
|
|
272
SEI Investments
SEIC
$12.6B
| $72 | ﹤0.01% |
1
| – | – |
2023 Q4
7 quarters
|
|
273
Garrett Motion
GTX
$4.56B
| $27 | ﹤0.01% |
2
| – | – |
2023 Q4
7 quarters
|
|
274
AdvanSix
ASIX
$446M
| $19 | ﹤0.01% |
1
| – | – |
2023 Q4
7 quarters
|
|
275
DELISTED
Hess
HES
| – | – |
-42
| Closed | -$5.82K | – |
|
Similar funds
APMC
DIG
RWIA
AWS
CPX
KCM
EHAM
FC
Fairman Group's Q3 2025 Portfolio in Review
As of Q3 2025, Fairman Group held 284 positions worth $124M, up 2.1% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Fairman Group's Q3 2025 filing shows 27 new, 59 increased, 25 reduced and 10 closed positions. Its largest new stake was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M. The largest sale was Essent Group, an estimated $1.46M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 54% a quarter earlier, followed by Technology and Financials.
- Fairman Group's largest Q3 2025 buy was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M.
- Fairman Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.18M increase.
- Fairman Group's biggest Q3 2025 reduction was Essent Group, cutting an estimated $1.46M.
- Fairman Group fully exited State Street SPDR Portfolio Developed World ex-US ETF in Q3 2025, selling an estimated $75.8K.
- Fairman Group's ten largest holdings make up 70% of its $124M portfolio in Q3 2025.
- Fairman Group opened 27 new positions and closed 10 in Q3 2025.
- Fairman Group's portfolio value rose 2.1% quarter-over-quarter to $124M.
Based on Fairman Group's 13F filing for Q3 2025, filed 31 Oct 2025.